Drug screening using islet cells and islet cell progenitors from human embryonic stem cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 21, 2015
Issued Date -
N/A
app pub date -
Apr 19, 2010
filing date -
Dec 7, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully